TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood vessel disease: upadacitinib shows promise
Disease control CompletedThis study looked at whether upadacitinib, a pill that targets inflammation, can help people with Takayasu arteritis that hasn't improved with standard treatments. The study included 12 adults with active disease. Researchers measured how many patients achieved complete or partia…
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Liu Tian • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Could a low-dose addiction drug ease vasculitis symptoms?
Symptom relief CompletedThis study tested whether a very low dose of naltrexone, a drug normally used for alcoholism, can improve physical health and quality of life in people with vasculitis (a group of rare blood vessel diseases). Sixty adults with different types of vasculitis took either the drug or…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Apr 29, 2026 15:05 UTC